Similarly, a modified RNA aptamer TTA1 against another ECM protein tenascin-C was tested in glioblastoma cells and later its efficient tumor uptake and durable blood retention were identified in mice bearing the xenograft tumors of breast, lung and colon, providing evidence that TTA1 may be potentially useful for tumor imaging and therapy [40-42]. The gene discussed is TNC; the disease is neoplasm.